Chemotherapy, AdjuvantAntineoplastic Combined Chemotherapy ProtocolsCarcinomaNeoplasm StagingBreast NeoplasmsCombined Modality TherapyPrognosisCarcinoma, Squamous CellDisease-Free SurvivalCarcinoma, HepatocellularTreatment OutcomeSurvival AnalysisCyclophosphamideFluorouracilNeoplasm Recurrence, LocalAdjuvants, ImmunologicSurvival RateAntineoplastic AgentsCisplatinLymphatic MetastasisNasopharyngeal NeoplasmsLiver NeoplasmsRadiotherapy, AdjuvantTumor Markers, BiologicalDoxorubicinAdenocarcinomaLung NeoplasmsMethotrexateColonic NeoplasmsFollow-Up StudiesNeoadjuvant TherapyRetrospective StudiesImmunohistochemistryStomach NeoplasmsDrug Administration ScheduleKaplan-Meier EstimateColorectal NeoplasmsNeoplasm MetastasisTegafurCarcinoma, Ductal, BreastEpirubicinAntimetabolites, AntineoplasticOvarian NeoplasmsAdjuvants, PharmaceuticCarcinoma, Non-Small-Cell LungFreund's AdjuvantLevamisoleTime FactorsPaclitaxelNeoplasm InvasivenessCarcinoma, Transitional CellCarcinoma, PapillaryCarcinoma in SituAnthracyclinesMastectomyProportional Hazards ModelsRectal NeoplasmsMultivariate AnalysisTaxoidsReceptors, EstrogenTamoxifenCarboplatinGene Expression Regulation, NeoplasticProspective StudiesUrinary Bladder NeoplasmsReceptor, erbB-2VinblastineEsophageal NeoplasmsHead and Neck NeoplasmsRandomized Controlled Trials as TopicLymph NodesCell Line, TumorKidney NeoplasmsRadiotherapyCarcinoma, Basal CellCarcinoma, Renal CellChemoradiotherapyCarcinoma, LobularClinical Trials as TopicOrganoplatinum CompoundsLymph Node ExcisionRadiotherapy DosageAntigens, NeoplasmCystectomyDisease Progressionalpha-FetoproteinsBone NeoplasmsPancreatic NeoplasmsAntineoplastic Agents, HormonalEtoposideLeucovorinGastrectomySarcomaCarcinoembryonic AntigenDeoxycytidineLomustinePredictive Value of TestsMouth NeoplasmsRisk FactorsPneumonectomy